Derivation of normative data for the COPD assessment test (CAT)

Respiratory Research

Volumn 15, Issue 1, 2014, Pages

  Pinto, Lancelot M ^a   Gupta, Nisha ^a   Tan, Wan ^b   Li, Pei Z ^a   Benedetti, Andrea ^a,d   Jones, Paul W ^c   Bourbeau, Jean ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

COPD assessment test; Health related quality of life; Normative data; Questionnaire

Indexed keywords

ADULT; AGE; AGED; ARTICLE; ASTHMA; CANADA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HIGH RISK PATIENT; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MUSCULOSKELETAL DISEASE; PHYSICIAN; PREDICTION; QUESTIONNAIRE; SEX DIFFERENCE; SMOKING; COPD ASSESSMENT TEST; CRONBACH ALPHA COEFFICIENT; DISEASE ASSOCIATION; FACE VALIDITY; HIGH RISK POPULATION; MIDDLE AGED; POPULATION RESEARCH; PSYCHOMETRY; VERY ELDERLY; LONGITUDINAL STUDY; PROCEDURES; PROSPECTIVE STUDY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STANDARDS; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; CANADA; COHORT STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; STATISTICS AS TOPIC;

EID: 84902742967     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-15-68     Document Type: Article

References (20)

1. Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thun MJ, Connell C, Jemal A, Lee TA, Miravitlles M, Aldington S, Beasley R. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006, 27:188-207.
2. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006, 28:523-532.
3. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013, 187:347-365.
4. Jones P, Harding G, Wiklund I, Berry P, Leidy N. Improving the process and outcome of care in COPD: development of a standardised assessment tool. Prim Care Respir J 2009, 18:208-215.
5. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J 2009, 34:648-654.
6. Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, Perez T, Soler Cataluna JJ, van der Molen T, Adamek L, Banik N. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J 2011, 38:29-35.
7. Tsiligianni IG, van der Molen T, Moraitaki D, Lopez I, Kocks JW, Karagiannis K, Siafakas N, Tzanakis N. Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med 2012, 12:20.
8. Jones PW, Shahrour N, Nejjari C, Lahlou A, Doble A, Rashid N, El Hasnaoui A. Psychometric evaluation of the COPD assessment test: data from the BREATHE study in the Middle East and North Africa region. Respir Med 2012, 106(Suppl 2):S86-S99.
9. Dodd JW, Marns PL, Clark AL, Ingram KA, Fowler RP, Canavan JL, Patel MS, Kon SS, Hopkinson NS, Polkey MI, Jones PW, Man WD. The COPD Assessment Test (CAT): short- and medium-term response to pulmonary rehabilitation. Copd 2012, 9:390-394.
10. Jones PW, Harding G, Wiklund I, Berry P, Tabberer M, Yu R, Leidy NK. Tests of the responsiveness of the COPD assessment test following acute exacerbation and pulmonary rehabilitation. Chest 2012, 142:134-140.
11. Mackay AJ, Donaldson GC, Patel AR, Jones PW, Hurst JR, Wedzicha JA. Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations. Am J Respir Crit Care Med 2012, 185:1218-1224.
12. Raghavan N, Lam YM, Webb KA, Guenette JA, Amornputtisathaporn N, Raghavan R, Tan WC, Bourbeau J, O'Donnell DE. Components of the COPD Assessment Test (CAT) associated with a diagnosis of COPD in a random population sample. Copd 2012, 9:175-183.
13. Nishimura K, Mitsuma S, Kobayashi A, Yanagida M, Nakayasu K, Hasegawa Y, Jones PW. COPD and disease-specific health status in a working population. Respir Res 2013, 14:61.
14. Bourbeau J, Tan WC, Benedetti A, Aaron SD, Chapman KR, Coxson HO, Cowie R, Fitzgerald M, Goldstein R, Hernandez P, Leipsic J, Maltais F, Marciniuk D, O'Donnell D, Sin DD. Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the Need for Longitudinal Observational Studies in COPD. COPD 2014, 11:125-132.
15. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007, 370:741-750.
16. Bland JM, Altman DG. Cronbach's alpha. BMJ 1997, 314:572.
17. Hopman WM, Towheed T, Anastassiades T, Tenenhouse A, Poliquin S, Berger C, Joseph L, Brown JP, Murray TM, Adachi JD, Hanley DA, Papadimitropoulos E. Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. Cmaj 2000, 163:265-271.
18. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-483.
19. Ware JE. The SF-36 health survey. Quality of life and pharmacoeconomics in clinical trials 1996, 337-346. Philadelphia: Lippincott-Raven.
20. Chovil AC. Healthy worker effect. J Occup med: official publication Ind Med Assoc 1986, 28:1189-1190.